Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Isatuximab On-Body Injector, Raising Anti-CD38 Competition in Myeloma
2
Setmelanotide Cuts BMI, Hunger in Phase 3 Trial for Hypothalamic Obesity
3
Upcoming 2026 FDA Decisions Could Expand Treatment Options Across Oncology and Hepatitis B
4
5 Notable FDA Approvals From the First Half of 2026
5